Entry and product release requirements for polypeptide product suppliers on ECHEMI.com

1.Introduction

1.1

Polypeptide drugs mainly include recombinant human insulin, octreotide acetate for injection, glucagon hydrochloride for injection, human insulin for injection, recombinant human insulin for injection, etc.

1.2

On www.echemi.com(called ECHEMI platfrom in the sequel), the sales of finished drugs are prohibited and suppliers who sell finished drugs will be strictly monitored.

At present, the display information of polypeptide products in some suppliers' stores involves content or pictures related to finished drugs. And there are cases of suppliers selling finished drugs to buyers. Due to the special function of the product, we ECHEMI platform demand the supplier to make rectifications of product information within a certain time limit. If suppliers are found to release relevant products in violation of regulations, ECHEMI platform will take appropriate penalties to eliminate such behavior.

1.3

ECHEMI platform will have different degrees of control over the joining of suppliers of polypeptide products and distribution of polypeptide products.

From now on, ECHEMI platform will strengthen the control and supervision of sixteen products, Tirzepatide, Semaglutide, Retatrutide, Supaglutide, Albenatide, Lixisenatide Acetate, Lixisenatide, Precose, Beinaglutide, Exenatide Acetate, Exenatide, Dulaglutide, Liraglutide, Setmelanotide, Setmelanotide, Efpeglenatide and  Adipotide, as well as their related finished drugs, and the relevant product catalog will be supplemented and notified later.

1.4

After submitting the relevant documents, user’s online shop can be verified successfully and then they can upload the related products.

2.Entry requirements

2.1 Product release requirements for existing suppliers of ECHEMI platform

2.1.1

Before February 9th, 2024, ECHEMI staff will contact the member suppliers who have uploaded the relevant products in the shop and sign the Commitment to Prohibit the sale of Finished Drugs on ECHEMI Platform with member suppliers.

2.1.2

Member suppliers involved in the operation of Tirzepatide, Semaglutide, Retatrutide, Supaglutide, Albenatide, Lixisenatide Acetate, Lixisenatide, Precose, Beinaglutide, Exenatide Acetate, Exenatide, Dulaglutide, Liraglutide, Setmelanotide, Setmelanotide, Efpeglenatide and Adipotide should provide the qualification certificates or Sales Authorization Letter of factories before February 9th, 2024. If the relevant documents are not provided, the relevant products in the shop will be forcibly removed from the ECHEMI platform.

2.1.3

If polypeptide products are involved in non-member supplier shops, the relevant products will be removed from the shelves by February 29th, 2024. After the suppliers provide the qualification certificates or Sales Authorization Letter of factories, they can contact

2.2 Follow-up entry requirements of domestic suppliers of ECEHMI platform

3. Why is this rule made?

In order to strengthen pharmaceuticals management, ensure pharmaceuticals quality, guarantee the public to use medicine safety and their rights and interests, protect and promote public health, and comply with the relevant laws and regulations of our state, only users with related certificates of Tirzepatide, Semaglutide, Retatrutide, Supaglutide, Albenatide, Lixisenatide Acetate, Lixisenatide, Precose, Beinaglutide, Exenatide Acetate, Exenatide, Dulaglutide, Liraglutide, Setmelanotide, Setmelanotide, Efpeglenatide and Adipotide can publish these products on www.echemi.com.

4. What are the penalties for breaking the rules?

If you do not comply with our network publishing rules, it may lead to a series of penalties, such as the illegal information directly deleted, related categories of products are restricted to release, the right to use your account is temporary, permanently closed account no longer cooperation and so on.

5. Supplementary provisions

5.1

Any violation of the supplier that occurred before the effective date of this management specification shall be applicable to the specifications at that time.

Any violation of the supplier that occur after the effective date of this management specification shall be applicable to this specifications.

5.2

ECHEMI can adjust this management specification at any time according to the operation of the platform and publicize it to users.

5.3

Suppliers shall comply with national laws, administrative regulations, departmental rules and other normative documents. Any act suspected of violating the national laws, administrative regulations, departmental rules and other normative documents, if there are provisions in this specification, they shall apply to this specification. If there is no provision in this specification, it shall be dealt with in accordance with laws and regulations. The relevant liability undertaken by the supplier in accordance with the relevant rules shall not exempt him from the legal liability. Any action of the supplier at www.echemi.com shall simultaneously comply with all agreements with ECHEMI and its affiliates.